IP Library Granted Patent US 8,993,329
Granted Patent B2
US 8,993,329 · App. 13/393,158 · Granted Mar 31, 2015

Method of efficiently establishing induced pluripotent stem cells

Inventors: Shinya Yamanaka (Kyoto, JP); Koji Tanabe (Kyoto, JP)
Assignee: Kyoto University
C12N5/0696C12N2501/602C12N2501/603C12N2501/604C12N2501/608C12N2510/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,993,329
App. No.
13/393,158
Granted
Mar 31, 2015
Kind
B2
Abstract

Provided are a method of improving iPS cell establishment efficiency, comprising the step of transferring Lin28B or a nucleic acid that encodes Lin28B to a somatic cell, particularly to a somatic cell on which Lin28 is ineffective or less effective than Lin28B in improving iPS cell establishment efficiency, and a method of producing an iPS cell, comprising the step of transferring Lin28B or a nucleic acid that encodes Lin28B and a nuclear reprogramming substance to a somatic cell. Also provided are an iPS cell comprising a nucleic acid that encodes Lin28B, that can be obtained by the method of producing an iPS cell, and a method of somatic cell production by forcing the iPS cell to differentiate into a somatic cell.

Claims (6)

1. A method of improving induced pluripotent stem (iPS) cell establishment efficiency, comprising transferring Lin28B or a nucleic acid that encodes Lin28B to a somatic cell undergoing nuclear reprogramming, wherein the nuclear reprogramming is brought about by contacting the somatic cells with nuclear reprogramming substances comprising (a) Oct3/4 or a nucleic acid that encodes Oct3/4, (b) Sox2 or a nucleic acid that encodes Sox2, and (c) Klf4 or a nucleic acid that encodes Klf4, thereby improving iPS cell establishment efficiency.

2. The method according to claim 1 , wherein the somatic cell is a somatic cell on which Lin28 is ineffective or less effective than Lin28B in improving iPS cell establishment efficiency.

3. A method of producing an iPS cell, comprising the step of transferring Lin28B or a nucleic acid that encodes Lin28B and nuclear reprogramming substances to a somatic cell, wherein the nuclear reprogramming substances comprise (a) Oct3/4 or a nucleic acid that encodes Oct3/4, (b) Sox2 or a nucleic acid that encodes Sox2, and (c) Klf4 or a nucleic acid that encodes Klf4, thereby producing an iPS cell.

4. The method according to claim 3 , wherein the nuclear reprogramming substances do not comprise Lin28 and a nucleic acid that encodes Lin28.

5. The method according to claim 3 , wherein the nuclear reprogramming substances are (a) Oct3/4 or a nucleic acid that encodes Oct3/4, (b) Sox2 or a nucleic acid that encodes Sox2, and (c) Klf4 or a nucleic acid that encodes Klf4.

6. The method according to claim 3 , wherein the somatic cell is a somatic cell on which Lin28 is ineffective or less effective than Lin28B in improving iPS cell establishment efficiency.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2012
From: YAMANAKA, SHINYA; TANABE, KOJI
To: KYOTO UNIVERSITY
Reel/Frame 028053/0291 →
Continuity (2)
Provisional Application 61245478 · Sep 24, 2009
Related Publication 20120214243A1 · Aug 23, 2012